 In New York, where Trump has already been convicted for falsifying business records, prosecutors said today they would agree to delay his sentencing, which was set for July 11th. A new drug for patients with early Alzheimer's disease now has FDA approval. Clinical studies found that Kusunla did not reverse, but rather slowed cognitive decline.